Gunderson Dettmer client Benchling, a life sciences research and development platform, raised a $50 million Series D financing led by Alkeon.

In an announcement of the financing Bencling CEO Saji Wickramasekara said, “This funding enables us to bring that same speed to life science as a whole, no matter the research area – oncology, food and agriculture, energy, or materials. In particular, with our upcoming products to support chemistry-based R&D and chemically-modified biomolecules, Benchling will soon become a singular solution for all of life science."